Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls Cecchin, Diego; Garibotto, Valentina; Law, Ian; Goffin, Karolien 2021
add to browser selection
Finding our way through the labyrinth of dementia biomarkers Chételat, Gaël; Arbizu, Javier; Barthel, Henryk; Garibotto, Valentina; ... Drzezga, Alexander 2021
add to browser selection
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 Morbelli, Silvia; Esposito, Giuseppe; Arbizu, Javier; Barthel, Henryk; ... Law, Ian 2020
add to browser selection
COVID-19 and the brain: impact on nuclear medicine in neurology Morbelli, Silvia; Ekmekcioglu, Ozgul; Barthel, Henryk; Albert, Nathalie L; ... Garibotto, Valentina 2020
add to browser selection
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias Chételat, Gaël; Arbizu, Javier; Barthel, Henryk; Garibotto, Valentina; ... Drzezga, Alexander 2020
add to browser selection
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia Nestor, Peter J; Altomare, Daniele; Festari, Cristina; Drzezga, Alexander; ... Frisoni, Giovanni 2018
add to browser selection
Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis Morbelli, Silvia; Arbizu, Javier; Booij, Jan; Chen, Ming-Kai; ... Barthel, Henryk 2017
add to browser selection
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives Morbelli, Silvia; Garibotto, Valentina; Van De Giessen, Elsmarieke; Arbizu, Javier; ... Pagani, Marco 2015